Skip to main content

Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations.

Publication ,  Journal Article
Zanaty, M; Chalouhi, N; Starke, RM; Jabbour, P; Hasan, D
Published in: Top Magn Reson Imaging
April 2016

Inflammation is increasingly being recognized as contributing to the underlying pathophysiology of cerebral aneurysms and brain arteriovenous malformation. Ferumoxytol is being increasingly used for both its prolonged intravascular imaging characteristics and its utility as an inflammatory marker when imaged in a delayed fashion. We aim to present a review article on the use of ferumoxytol to assess cerebral aneurysms and arteriovenous malformation. This could potentially help assist the physician in his judgment for intervening, as aneurysms that look macroscopically the same may behave differently.

Duke Scholars

Published In

Top Magn Reson Imaging

DOI

EISSN

1536-1004

Publication Date

April 2016

Volume

25

Issue

2

Start / End Page

57 / 61

Location

United States

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • Magnetic Resonance Imaging
  • Intracranial Arteriovenous Malformations
  • Intracranial Aneurysm
  • Humans
  • Ferrosoferric Oxide
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zanaty, M., Chalouhi, N., Starke, R. M., Jabbour, P., & Hasan, D. (2016). Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations. Top Magn Reson Imaging, 25(2), 57–61. https://doi.org/10.1097/RMR.0000000000000086
Zanaty, Mario, Nohra Chalouhi, Robert M. Starke, Pascal Jabbour, and David Hasan. “Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations.Top Magn Reson Imaging 25, no. 2 (April 2016): 57–61. https://doi.org/10.1097/RMR.0000000000000086.
Zanaty M, Chalouhi N, Starke RM, Jabbour P, Hasan D. Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations. Top Magn Reson Imaging. 2016 Apr;25(2):57–61.
Zanaty, Mario, et al. “Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations.Top Magn Reson Imaging, vol. 25, no. 2, Apr. 2016, pp. 57–61. Pubmed, doi:10.1097/RMR.0000000000000086.
Zanaty M, Chalouhi N, Starke RM, Jabbour P, Hasan D. Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations. Top Magn Reson Imaging. 2016 Apr;25(2):57–61.

Published In

Top Magn Reson Imaging

DOI

EISSN

1536-1004

Publication Date

April 2016

Volume

25

Issue

2

Start / End Page

57 / 61

Location

United States

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • Magnetic Resonance Imaging
  • Intracranial Arteriovenous Malformations
  • Intracranial Aneurysm
  • Humans
  • Ferrosoferric Oxide